Metaplanet
3350
Remixpoint
3825
Nippon Telegraph & Telephone
9432
4
Mitsubishi Heavy Industries
7011
5
AEON Mall
8905
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 44
- 00.00%
20min DelayTrading Mar 3 10:49 JST
3.87BMarket Cap-2.42P/E (Static)
45High44Low60.60KVolume44Open44Pre Close2.69MTurnover9052wk High0.07%Turnover Ratio87.95MShares4152wk Low-16.51EPS TTM3.67BFloat Cap2229Historical HighLossP/E (Static)83.40MShs Float41Historical Low-18.21EPS LYR2.27%Amplitude--Dividend TTM3.14P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Ryo Yamada
- Director
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Hirotaka Takeuchi
- Independent Director
- --